Clinical Trial Update: Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the anesthetic topical adhesive Synera to reduce pain from subcutaneous injections of multiple sclerosis medications; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Synera (lidocaine/tetracaine patch)

Snippet

Sponsor: Brown, Theodore R., M.D., MPH | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2018-03-13